Drug intelligence / Profile preview

Pascoflair Night

Development stage: Unknown
Lead developer: Pascoe Naturmedizin
Modality: Small Molecules
Administration: Oral

Overview

Pascoflair Night is a natural herbal sleep aid developed by Pascoe, a German company specializing in natural medicine. It is formulated as a combination of three botanical extracts: lemon balm leaf (*Melissa officinalis*), valerian root (*Valeriana officinalis*), and passionflower herb (*Passiflora incarnata*). The product is indicated for the treatment of sleep disturbances and to provide sleep support, particularly during times of mental stress and nervous tension. Unlike melatonin-based aids, it is hormone-free and marketed as non-habit-forming with no morning grogginess. It was launched in Canada in 2022 and is manufactured in Germany using advanced extraction methods.

Brand names: Pascoflair Night

Beyond the preview

Go deeper on Pascoflair Night.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pascoflair Night.

Explore the full profile